CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRDL fundamentals
Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.0862 (YoY +35.19%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.0862
+35.19%
Report date
Nov 13, 2025
EPS
Actual | -0.1292 | -0.1813 | -0.087 | -0.1119 | -0.0776 | -0.0939 | -0.0885 | -0.0813 | -0.0905 | -0.0662 | -0.0905 | -0.1033 | -0.0731 | -0.133 | -0.0695 | -0.0695 | -0.0735 | -0.0862 |
Forecast | -0.1131 | -0.1103 | -0.1107 | -0.1359 | -0.1009 | -0.1048 | -0.059 | -0.0813 | -0.0943 | -0.0883 | -0.0905 | -0.0883 | -0.1033 | -0.0942 | -0.0881 | -0.0799 | -0.0808 | -0.0715 |
Surprise | -14.24% | -64.37% | +21.41% | +17.66% | +23.09% | +10.40% | -50.00% | 0.00% | +4.03% | +25.03% | 0.00% | -16.99% | +29.24% | -41.19% | +21.11% | +13.02% | +9.03% | -20.56% |
Revenue
Actual | 63.60K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Cardiol Therapeutics's latest dividend and current dividend yield?Did Cardiol Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Cardiol Therapeutics next quarter?What guidance did Cardiol Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Cardiol Therapeutics year over year?What were the key takeaways from Cardiol Therapeutics’s earnings call?What were the key takeaways from Cardiol Therapeutics's earnings call?What does Cardiol Therapeutics do and what are its main business segments?
